chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning a male who on Sept 21 2004 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #647271/1138N). on approximately Sept 22 2004 the patient developed redness from his shoulder to his wrist (site unspecified), and reported that the area was very painful and appeared to be swollen. the patients outcome was unknown. The LPN reported that the patient had received vaccinations with pneumococcal 23v polysaccharide vaccine in the past without incident. Additional information has been requested. The LPN also reported a male patient who developed similar events after vaccination with pneumococcal 23v polysaccharide vaccine (lot 647271/1138N) (WAES0410USA004371).
At around 2 AM the night after the vaccine (5/1), I woke up feeling extremely cold and aching all over. This lasted until around 3 AM on 5/2. I also had occasional slight headaches during the day on 5/1. After the fever symptoms went away, the were immediately replaced by: runny nose, sneezing, some coughing, a slight wheeze (only lasted from 3 AM to 4 AM), slight chest tightness, itchy mouth/tongue, and throat tightness. All of those lasted until around 11 AM on 5/2. Only a slight throat tightness remains now (noon on 5/2).
A report has been received from health professional concerning a 3 year old female patient. The patient's medical history included nose bleeds. The patient's concurrent disease included seasonal allergies. The patient has been receiving FLUMIST quadrivalent (intranasal) started on 03-Nov-2014. On 03-Nov-2014, the patient developed a nose bleed after receiving FLUMIST quad. right after the administration, the patient's nose began to bleed. Pressure was applied and the bleeding stopped in about two minutes. The parent said that the patient was prone to nosebleeds. There was no significant medical history; the patient was healthy. The report was considered to be non-serious by reporter.
It started off with a raw throat, swallowing a lot, tired, dry cough, and nose started pouring like a bucket. I went to the hospital drive thru to get a COVID-19 test and it was positive. They gave me medicine and I took it for three days when needed. Then I tested positive for COVID-19 again on 10/30/2022 at home. I had the same symptoms as before but milder.
Her Mom, experienced chills for two hrs; She vomited; Fatigue; Fever; This is a spontaneous report from a contactable consumer (reported for mother) via Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient had experienced chills for two hours then she vomited, got fatigue and fever. The outcome of the events was unknown.   Follow-up attempts have been completed and no further information is expected.
Lethargic, nausea, vomiting, glassy eyes, no appetite, fever 102.0. Started 30 min after vaccine. Given Zofran and Levison.
Chest pain acutely with chills - started on the evening of 02/27/2019 and went into the morning of 02/28/2019 - vitals signs were obtained and were in within normal limits.
6 hours after my shot I had a high fever, and for the next 24 hours I had a fever on and off, muscle aches, no appetite, moderate to severe pain at injection site with redness and swelling, and fatigue. I took generic Tylenol around 6:30 the day after my shot which improved my condition
Pt vaccinated with Recombivax HB MD reported pt developed multiple sclerosis following vaccination w/Hepatitis B vaccine RECOMBINANT.
Herat rate increased/Elevated heart rate, 137-154 bpm during standing and walking; second dose of Moderna Covid-19 Vaccine last 11Aug2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Aug-2021 and was forwarded to Moderna on 12-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Herat rate increased/Elevated heart rate, 137-154 bpm during standing and walking) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of Moderna Covid-19 Vaccine last 11Aug2021) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of Moderna Covid-19 Vaccine last 11Aug2021). On 11-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEART RATE INCREASED (Herat rate increased/Elevated heart rate, 137-154 bpm during standing and walking). On 11-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of Moderna Covid-19 Vaccine last 11Aug2021) had resolved. At the time of the report, HEART RATE INCREASED (Herat rate increased/Elevated heart rate, 137-154 bpm during standing and walking) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Aug-2021, Heart rate: 137-154 (High) elevated heart rate,137-154 bpm during standing and walking..         Concomitant product information was not provided. Treatment information was not provided   This case was linked to MOD-2021-284948 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Additional information received and patient demographics were updated.Dose 2 details were added. Event Inappropriate schedule of vaccine administration event was added.
Shortly after vaccination the pt experienced a headache and nausea. the pt sought unspecified medical treatment. Subsequently the pt recovered from nausea and reported that she will not be receiving the second vaccination.  No further information is available.
This spontaneous report as received from a pharmacist to a 64 years old female patient with no drug reactions/allergies. The patient was subcutaneously vaccinated with a dose of 0.65 ml ZOSTAVAX (Lot# unspecified) on 03-SEP-2012. Then the patient returned to the pharmacy on 05-SEP-2012 to report that on the day following the vaccination (04-SEP-2012) she developed a rash, with pruritus and erythema at the injection site. The patient had sought medical attention via returning to pharmacy. No treatment was given for the adverse event. The outcome was reported as not recovered/not resolved. Additional information is not expected.
pt recvd vax 24OCT95 & pt devel a red & white, confluent, itchy, maculopapular rash that originated in the diaper area & spread to chest, arms & head;no vesicular lesions were present;
Soreness at injection site; This is a spontaneous report from a contactable consumer (patient) and healthcare professional (HCP). A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) solution for injection via an unspecified route of administration on 18Dec2020 at 10:30 (at the age of 52-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included HTN (hypertension) and known allergies sulfa. Concomitant medications included pneumococcal vaccine polysaccharide 23valent (PNEUMOVAX 23) on 14Dec2020 in right deltoid and varicella zoster vaccine RGE (CHO) (SHINGRIX) on 14Dec2020 in left deltoid. The patient did receive other vaccines (PNEUMOVAX 23 and SHINGRIX) within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 18Dec2020, the patient experienced soreness at injection site. No treatment was provided for the event soreness at injection site. The outcome of the event soreness at injection site was recovered in Dec2020. Since the vaccination, the patient has not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
chills; fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported.  Concurrent medical conditions included Cholesterol high and Hypertension. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.            Concomitant products also included Cholesterol Medicine 5mg, Blood pressure Medicine 5mg.
She recieved a flu shot 10/25/7 in my office. She has reported constant pain in the arm originating in the area of the injection since.  She saysd that it was very bad for the first 2 months but that it is getting better.  She felt that the area under her arm was also swollen (she thought from lymphnodes) and that the pain starts inher deltoid and it is "piercing".  She can have pain into her neck and she has some decrease range of motion in the shoulder now. She is very certain that this started after her flu shot.
tonic sz x 15 mins w/apnea x 3 mins; postical exam; EEG-nl toxicology-nl; 22APR94 MRI;
passing out; vomiting; tingling; severe pain shoulders; tingling/severe pain shoulders and all of back/torso, legs ached; tingling/severe pain shoulders and all of back/torso, legs ached; pain all over/torso; slight head ache; chills/cold; chills/cold; turned to temp 99.9; very warm/uncomfortable; fatigue; This is a spontaneous report from a non-contactable nurse (patient). This 45-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL3249), via an unspecified route of administration on 29Jan2021 09:30 at single dose in the left arm for COVID-19 immunization. The patient's medical history was none. No known allergies. The patient's concomitant medications included naproxen (occasional) in two weeks. The patient previously took first dose of bnt162b2 (Lot number: EK9231), on 07Jan2021 at left arm for COVID-19 immunization. Facility type vaccine was hospital. No other vaccine received in four weeks. Patient got vaccine at 9:30am. Woke up morning (30Jan2021) after the vaccine about 9:30am with tingling/severe pain shoulders and all of back/torso, legs ached. During shower at that time, very close to vomiting/passing out. Took NSAID and slept. Then paracetamol (TYLENOL) mid day. That evening had fatigue and pain all over, slight head ache, chills/cold and then turned to temp 99.9, very warm/uncomfortable. Paracetamol again that night before bed. Woke on Sunday better just fatigue and achy. No treatment received. No COVID prior vaccination. No COVID tested post vaccination. Outcome of the events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
high fever, headache, joint aches, nasuea, chills, shakes, loss of apetite.   called dr and pharmcy
07/15/2005 - Right deltoid 11.7 x 15cm erythema, right axilla and chest 15 x 15cm erythema and edema tender to palpation.  Treated with aspirin, cool compress.  07/18/2005 - resolved.
Palms of hands itched tremendously and turned bright red, 11 days after #2 which was unexpected.; Palms of hands itched tremendously and turned bright red, 11 days after #2 which was unexpected.; Barely sore arm  after dose 2; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6205 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 11Mar2021 at 11:00 (at the age of 71-year-old) as DOSE 2, SINGLE for covid-19 immunization.  Medical history included 17 years post endometrial/ovarian CA, Stage 1 and arthritis. The patient doesn't have any allergy to medications, food, or other products. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6200 and expiration date: not reported), via an unspecified route of administration, in Left Arm, on 15Feb2021 at 11:00 (at the age of 71-year-old) as DOSE 1, SINGLE for covid-19 immunization and experienced Extremely sore arm up into neck, chest congestion with coughing lasting 45 minutes, palms of hands itched tremendously and turned bright red, Brain Fog, fatigue, muscle weakness, nausea, slight diarrhea. Concomitant medication included ibuprofen (ADVIL) taken for arthritis. The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On Mar2021, 11 days after dose 2, the patient experienced palms of hands itched tremendously and turned bright red, which was unexpected and on an unspecified date in 2021 after dose 2, barely sore arm. The outcome of the events was recovering at time of report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a pharmacist concerning a female patient of unknown age. The patient's medical history included feeling an itchy tingle on her lip, cold sore and tongue cancer, she finished radiation 1 year ago in July 2013, currently in remission. On 24-NOV-2014, the patient was vaccinated with a dose of ZOSTAVAX (dose, dose number, lot number and expiration date were not reported), subcutaneous. Concomitant therapies included EPISOL and STATIN. The patient stated that on 25-NOV-2014 (reported as this morning), she had a cold sore on her lip. She stated that she has had three cold sores in the past, and that they were little and not as painful as the current cold sore. She stated that the pain radiates down her jaw, and that she was also having eye pain on the same side. At the time of the report the outcome was reported as not recovered. Patient did not performed lab diagnostic test. Patient seek for medical attention at the pharmacy, but did not received treatment for the events. Additional information has been requested.
Patient presented to the vaccination site on 12/11/21. Client received booster Pfizer dose (LOT#: FF8841) on 12/11/21 at 1346. The client notified EMT that he felt like he "will faint." Patient stated that he has a history of anxiety and hand tingling occurs with his anxiety. Patient stated that he also has a needle phobia that occurs when he donates blood. Patient is not on any medications. Patient received Pfizer first dose on 4/3/21 and second dose 5/01/21. EMT took clients vital signs. BP: 110/78, HR: 65, O2: 99% at 1351. Client did not report any new symptoms. Client able to drink water. EMT retook vital signs at 1400. BP: 110/82, HR: 68, O2: 100%. Client did not report any new symptoms. EMT retook patients vital signs at1416. BP: 110/80, HR: 66, O2: 99%. Patient did not report any new symptoms. Patient completed his 30 minutes of observation. Patient stated that his girlfriend was driving him home. Patient left vaccination site at 1417 unassisted with a steady gait with his girlfriend.
4 days after vaccine: cold sweats, fatigue; on 3/8 developed Bells palsy
no adverse event, moderna confirmed 216K22A was viable until 2/21/23 despite beyond use date of 1/22/23
Information has been received from a Nurse Practitioner concerning an 80 year old male patient who on 12-MAR-2007 was vaccinated with his first dose of Pneumovax 23, lot #655668/1004F.  On 12-MAR-2007 he developed an injection site reaction described as redness, swelling, heat and pain from the elbow up.  On 13-MAR-2007 the patient was seen in the office.  At the time of the report his symptoms were persisting.  The reporter indicated that two other patients developed injection site reactions after receiving Pneumovax 23, and requested a lot check be performed on lot #655668/1004F.  The records of testing prior to the release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency, and was released.  Additional information has been requested.
High fever (up to 104), severe chills, unable to eat, very weak, headache.....this is day 4...just beginning to feel a bit better
This spontaneous report was received from a patient's mother concerning to her 3.5 years old male son. The patient did not have any medical history or drug reaction/allergy. No concomitant medications were reported (also reported as topical silver sulfadiazine cream  on his burn). On 20-DEC-2016, the patient was vaccinated with VARIVAX 0.5ml once, injection into the leg (unspecified leg) (lot number and expiration date were not reported) for prevention (prophylaxis). Subsequently, on the same date (reported  as since the patient got the vaccination) the patient "got a burn on his hand" (thermal burn). On approximately 29-DEC-2016 (reported as 5 or 6 days ago), the patient developed "little bumps that look like flea bites. The first one was at the injection site on his leg (injection site mass), Subsequently, on 31-DEC-2016 (reported as two days later), another one appeared on his belly (skin mass), and on 04-JAN-2017 (reported as this morning) the patient had another two on his neck (neck mass). It was reported that the patient did not have fever and felt fine, however, the reporter spoke with the patient's doctor's office by phone. A topical silver sulfadiazine cream had been used for the local burn, but no treatment was given for the little bumps. No laboratory diagnostic was performed and a product quality complaint was not involved. At the time of the report, the outcome of the events was reported as not recovered.  The causal relationship between the events and VARIVAX was not reported. Additional information has been requested.
12:48 Pt. arrived in observation area post injection with numbness in jaw( bilateral ) and tingling of tongue."Some swelling of tongue" stated by pt. 12:49  Vitals taken,(BP 166/100, O2sat.98, HR 74, respirations 22) Field supervisor notified and present. 12:50   Clinical assessment done -no respiratory distress but anxiety ,no increase in symptoms. Stayed with pt. for 30 mins as symptoms resolved within this time frame.All symptoms resolved before pt. was released. Pt. had passenger who could be with her for the rest of the day. Pt. was instructed to call EMS if symptoms returned. 1320     Pt. felt comfortable driving and left the clinic.
Day 3, sudden, unexpected acute pain in left ankle. Swelling. Tender when touched. Unable to walk. Stiffness.
91y/o F home care pt with known dementia became bed bound a few days after COVID vaccine in Feb 2021. MD was not notified at the time and dtr is not sure there is a correlation as she has been slowing down gradually even prior.
No symptomatic / adverse events reported. Expired 0.3 mL Pfizer 12+ older dose administered. Expired by 5 days. Directed by Dept of Health and Pfizer to file VAERS report.
Patient stated that he experienced vomiting for about an hour and a half, slight headache, and diarrhea for about 7-8 hours.  The patient stated that he had ate food at a friends house but stated that no other person who ate had gotten sick.  He also stated that he had received other injections from MD which included a steroid shot an an unknown injection stated by the patient. I tried to call Dr to see which injections were given but was unable to reach him.  The patient did say that he felt normal with no ill effects from the day previous.
patient reported itching to below arms and chest. This progressed to the upper back area. she denied shortness of breath, trouble breathing or rash. She has no previous reactions to vaccines and did not take  this morning. she has allergies to Penicillins and Omnicef. No improvement to pruritus.  so patient was given 25 mg of Benadryl. she was instructed , it can cause drowsiness. patient or guardian instructed to notify primary care physician of reaction to ensure safety to receive  second dose. patient instructed to notify medical Doctor if situation worsen or don't improve in 5 to 10 minutes.
devel confirmed case of measles 2 days post vax;sx rash, fever, sore throat, lymphadenopathy;
I got my first Pfizer vaccine injection on 3/23/2021 and felt no immediate side effects, but almost exactly 1 week later I noticed slight dizziness. Yesterday it was more apparent and today I woke up with it worse. It worried me and I found myself a bit panicky and my heart was racing. When I calm down, heart rate is fine.    It's more noticeable today. Not to the point of nausea, nor full vertigo, but I feel kinda foggy and unsure about my balance
Acute periods of heightened sense of smell; severe restless legs symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms). At the time of the report, DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not provided. Treatment received APPLE CIDER VINEGAR .   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non-significant follow-up case booked inAE contact information was updated.contact information updated. She prefers being contacted via email.
This spontaneous report was received from a consumer concerning an unspecified patient (demographics unknown). The patient's pertinent medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with a dose of M-M-R II (dose, route and lot# not provided). On an unknown date, the patient was diagnosed with autism and attention deficit/hyperactivity disorder (ADHD). At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information is not expected, no contact details were provided.
syncope and collapse. started feeling faint and collapsed while sitting in car with dad. episode lasted 20-30min and she was in and out of consciousness during that time per dad. She was very pale at the time, eyes deviated back. no tonic clonic features. + emesis and dry heaving for 15-20min following the event. when she came to her underwear was wet, believe she may have lost continence of urine. no stool incontinence. Marked fatigue following the event. She did have WCC and vaccines earlier that day, Tdap, MCV, HPV. Hx of vasovagal responses to pain in the past, usually immediately following pain. did have emesis in response to pain from a bee sting in the past. No prior Hx of incontinence of urine.